A comparison of self-reports of distress and affective disorder diagnoses in rheumatoid arthritis: A receiver operator characteristic analysis by McQuillan, Julia et al.
University of Nebraska - Lincoln 
DigitalCommons@University of Nebraska - Lincoln 
Bureau of Sociological Research - Faculty 
Publications Bureau of Sociological Research (BOSR) 
June 2003 
A comparison of self-reports of distress and affective disorder 
diagnoses in rheumatoid arthritis: A receiver operator 
characteristic analysis 
Julia McQuillan 
University of Nebraska - Lincoln, jmcquillan2@Unl.edu 
Judith Fifield 
University of Health Center, Farmington, Connecticut 
T. Joseph Sheehan 
University of Health Center, Farmington, Connecticut 
Susan Reisine 
University of Health Center, Farmington, Connecticut 
Howard Tennen 
University of Health Center, Farmington, Connecticut 
See next page for additional authors 
Follow this and additional works at: https://digitalcommons.unl.edu/bosrfacpub 
 Part of the Sociology Commons 
McQuillan, Julia; Fifield, Judith; Sheehan, T. Joseph; Reisine, Susan; Tennen, Howard; Hesselbrock, Victor; 
and Rothfield, Naomi, "A comparison of self-reports of distress and affective disorder diagnoses in 
rheumatoid arthritis: A receiver operator characteristic analysis" (2003). Bureau of Sociological Research - 
Faculty Publications. 12. 
https://digitalcommons.unl.edu/bosrfacpub/12 
This Article is brought to you for free and open access by the Bureau of Sociological Research (BOSR) at 
DigitalCommons@University of Nebraska - Lincoln. It has been accepted for inclusion in Bureau of Sociological 
Research - Faculty Publications by an authorized administrator of DigitalCommons@University of Nebraska - Lincoln. 
Authors 
Julia McQuillan, Judith Fifield, T. Joseph Sheehan, Susan Reisine, Howard Tennen, Victor Hesselbrock, 
and Naomi Rothfield 
This article is available at DigitalCommons@University of Nebraska - Lincoln: https://digitalcommons.unl.edu/
bosrfacpub/12 
Introduction
Elevated levels of emotional distress indicated by de-
pressive symptoms [1-4], diagnoses of depression [5-8], 
and anxiety [3] are reported consistently across studies of 
rheumatoid arthritis (RA) patients. Two reasons individu-
als with RA may be at greater risk for depression than the 
general population are high levels of pain and/or func-
tional impairment or a common neurobiologic mechanism 
underlying both depression and RA [9-11]. An important 
rival hypothesis is that elevated levels are a measurement 
artifact.
An accurate assessment of the scope of emotional dis-
tress is important and researchers exploring a connection 
between RA and affective disorders need reliable and valid 
brief scales for screening individuals. Unfortunately, scores 
on the most frequently used measures of psychological dis-
tress (screening scales) may be inflated for a variety of rea-
sons, calling into question the meaning currently ascribed 
to the high distress levels seen in RA samples [1, 2, 8, 12]. 
The problems stem from 3 sources: 1) findings have not been 
based on large, representative samples of RA patients; 2) 
many depression and anxiety scales have adequate conver-
gent validity but low discriminant validity; and 3) there may 
be overlap between emotional distress items and typical RA 
symptoms, i.e., criterion contamination [13]. There is particu-
lar concern that distress detected by the widely used Center 
for Epidemiological Studies Depression Scale (CES-D) might 
not be due to anxiety, depression, or concurrence of the two, 
but rather that it is an artifact of overlap between CES-D so-
matic items and RA disease severity [1, 2, 11].
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Abstract
Objective—To compare 3 commonly used psychiatric symptom checklists (the Center for Epidemiological Studies Depression 
Scale [CES-D], the Positive and Negative Affect Schedule, and the Endler Multidimensional Anxiety Scales [EMAS] to deter-
mine their sensitivity, specificity, and ability to discriminate between a disorder (Major Depression [MD], Generalized Anx-
iety Disorder [GAD], and no disorder. To compare the checklists for their ability to discriminate between type of disorder 
(MD and GAD). To evaluate the discriminant ability of the subscales, particularly positive affect; whether the somatic items 
in the CES-D artificially inflate affective scores; and the optimal cut off score for the CES-D.
Methods—We compared the 3 scales to diagnostic criterion of MD, GAD, and comorbid disorder using receiver operator charac-
teristic (ROC) and logistic regression analyses. The sample consisted of a national panel of 415 individuals with rheumatoid 
arthritis (RA).
Results—Each of the scales had high sensitivity and specificity (areas under the curve: CES-D = 0.92, negative affect = 0.88, posi-
tive affect and EMAS = 0.82). The CES-D, however, demonstrated better sensitivity and specificity than the positive affect and 
the EMAS, but not the negative affect scale.
Conclusion—All 3 self-reports have high combined sensitivity and specificity as measures of affective disorders among RA 
patients.
Keywords: affective disorder, distress, ROC
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To address these limitations and to test the measure-
ment artifact hypothesis, we employed a large, nationally 
representative sample; used a structured diagnostic inter-
view; used a multidimensional approach to enhance dis-
criminant validity of screening scales suggested by Clark 
and Watson [14]; and compared the combined sensitivity 
and specificity of the CES-D with and without the somatic 
items using receiver operator characteristic (ROC) curves. 
This study also provides information to determine appro-
priate cut off scores for major depression (MD) and gen-
eralized anxiety disorder (GAD) for the continuous scales 
commonly used on the RA population [15-18].
The intensity of depressive symptoms among individ-
uals with RA has been widely studied using various indi-
cators, including the CES-D [1, 2, 11], the Beck Depression 
Inventory (BDI) [19, 20], and the Arthritis Impact Measure-
ment Scales [3, 19, 21-23]. In samples of individuals with 
RA, and using the conventional cut off for general popu-
lations, investigators have found rates of depression rang-
ing from 23% using the BDI to 46% using the CES-D [1]. 
Although anxiety symptoms among RA patients have been 
studied less frequently than symptoms of depression, stud-
ies that have assessed anxiety report rates comparable to 
that reported for depression [3, 19].
When individuals with RA report high levels of psy-
chological distress, it is not clear that researchers should 
be reporting their findings as evidence of depression. Brief 
self-report scales are economical and often have good con-
vergent validity (indicated by high correlations with other 
measures of the same construct), but they do not have good 
discriminant validity (indicated by high correlations with 
other measures of related but not identical constructs). It 
is possible, of course, that while the underlying constructs 
may be conceptually distinct, they may be empirically co-
linear. As a result, anxiety measures correlate or load 
highly with depression measures and it is unclear whether 
the distress that is being measured is due to anxiety, de-
pression, or both [3, 12, 19, 24-26].
The somatic items included in most measures of depres-
sion and anxiety leave open the possibility of criterion con-
tamination [13]. This contamination occurs when items that 
were designed to assess dimensions of depression or anxiety 
actually reflect aspects of RA. For example, questions about 
fatigue or difficulty “getting going” can reflect depression, 
the effects of RA, or both. Callahan et al [27] and Blalock et al 
[1] found evidence consistent with the idea that the somatic 
items of the CES-D are elevated among RA patients due to 
RA symptoms, not greater depression. Rhee et al [11] found 
some inflation of total CES-D scores in an RA sample attrib-
utable to somatic items. Blalock and colleagues [1] recom-
mended that investigators remove 4 CES-D items to reduce 
the inflation in scores deriving from RA disease severity.
These problems with common self-report screening 
questionnaires have compromised our understanding of 
connections between RA and affective disorders. Fortu-
nately, methods are now available to improve the discrimi-
nant validity of questionnaire measures to differentiate be-
tween depression and anxiety. Two such methods are used 
in this study. The first is a measure of state anxiety that 
was designed specifically to distinguish anxiety from de-
pression [25]. The second approach is based on the assess-
ment of positive affect (PA) and negative affect (NA), as 
suggested by Clark and Watson [14]. NA refers to feeling 
“upset or unpleasantly engaged rather than peaceful,” and 
PA refers to feeling a “zest for life and pleasurable engage-
ment” [14]. These 2 affects can be measured as distinct and 
orthogonal factors [14]. They discriminate between anxiety 
and depression because NA is associated with both depres-
sion and anxiety, but low PA is unique to depression. These 
findings have been reported in nonclinical [28, 29] and clin-
ical samples [30-32]. In this study, we assess whether the 
discriminant validity of the CES-D can be increased by us-
ing 2 subscales of the CES-D, identified in our previous 
work [33], that closely resemble PA and NA.
In summary, we pose the following questions: 1) 
Which of the commonly used distress scales demonstrates 
the highest sensitivity and specificity? 2) Do subscale scores 
improve our ability to distinguish between anxiety disor-
ders and depressive disorders, and does the measurement 
of PA enhance this distinction? 3) Do somatic items in de-
pression scales, such as the CES-D, artificially inflate re-
ports of the prevalence of affective disorder among indi-
viduals with RA, and does removing those items improve 
scale sensitivity and specificity? 4) What is the optimal cut 
off score on the widely used CES-D to detect affective dis-
order in a nationally representative RA sample?
Patients And Methods
Patients. A subset of patients from the National Rheu-
matoid Arthritis Study (NRAS) were recruited for this proj-
ect. NRAS was a prospective panel study that completed its 
tenth and final year in 1997-1998. The panel of 988 patients 
with classic or definite RA [34] was recruited from a na-
tional, random sample of board-certified rheumatologists 
(details of the recruitment are published elsewhere [[35]]. 
At the close of their eighth year interview, the 508 patients 
remaining in the panel were asked if they would be inter-
ested in participating in an additional interview about their 
emotional and physical well being. A total of 462 (91%) 
agreed to the followup interview and 415 (90%) completed 
it. Consistent with the 3:1 prevalence of RA among middle-
aged women to men, 83% of the sample was female. They 
were largely upper middle-aged (mean 58 ± SD 9.7 years), 
married (68%), and out of the labor force (65%). The rela-
tively low employment rate is similar to other samples of 
RA patients [36].
Methods. Diagnostic and scale responses were ob-
tained by telephone interviews that lasted approximately 
30 minutes. Current and lifetime psychiatric diagnoses of 
MD, GAD, and comorbid disorder (CD) were obtained us-
ing the Semi-Structured Assessment for the Genetics of Al-
coholism (SSAGA) [37-39] based on the Diagnostic and Sta-
tistical Manual of Mental Disorders, Fourth Edition (DSM-IV) 
[40]. The SSAGA is suitable for either telephone or face-to-
face administration by lay interviewers [38, 39].
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The SSAGA was selected because it provides a com-
plete and detailed lifetime psychiatric history for adults. 
The SSAGA interview schedule covers the major Diagnostic 
and Statistical Manual of Mental Disorders Revised Third Edi-
tion, DSM-IV, International Classification of Diseases, 10th Re-
vision defined Axis I psychiatric disorders. In a combined 
sample of subjects drawn from the general population and 
from outpatient psychiatric patients, the SSAGA has been 
shown to have good within and between site reliability 
[37]. Using a combined sample of outpatient psychiatric 
patients and subjects drawn from the community with un-
known psychiatric histories, the SSAGA has been shown to 
be valid compared with other standardized psychiatric di-
agnostic instruments, i.e., the Schedule for Clinical Assess-
ment in Neuropsychiatry (SCAN) [38]. The SSAGA is cur-
rently being used in more than 55 studies in the US and 10 
studies in foreign countries.
The SSAGA is useful in the arthritis population because 
it links episodes of MD or GAD to comorbidities and flares. 
Interviewers, supervised by a clinical psychologist, com-
pleted approximately 20 hours of SSAGA training. All of the 
interviews were edited for accuracy by a research staff mem-
ber with a master’s degree in psychology and several years 
of experience with development of the interview.
Measures. The Center for Epidemiological Studies Depres-
sion Scale. The CES-D scale consists of 20 questions chosen 
to reflect various aspects of depression, including depressed 
mood, feelings of guilt and worthlessness, feelings of help-
lessness and hopelessness, psychomotor retardation, loss of 
appetite, and sleep disturbance [41]. Respondents are asked 
to think of the last week and report the frequency of occur-
rence for each item on the following 4-point scale 0) rarely, 
that is less than 1 day; 1) some of the time, 1 to 2 days; 2) a 
moderate amount of the time, 3 to 4 days; or 3) most or all 
of the time, 5 to 7 days. Scores can range from 0-60. Anesh-
ensel et al [42] found that phone and in person administra-
tions produce comparable scores. Past studies show that the 
CES-D demonstrates adequate test-retest stability, as well as 
concurrent validity and construct validity [41].
Although the CES-D appears to suffer from the same 
discriminant validity problems as other popular depres-
sion questionnaires used in arthritis research [1], it has 
been chosen for this study for 3 reasons. First, along with 
the BDI, it has been rated among the best self-report mea-
sures of depression and anxiety based on content validity 
[43]. Second, it has been widely used for some time among 
arthritis researchers, and knowledge about its validity or 
how to improve it would be very useful in the analysis of 
data appearing in the literature. Finally, previous analy-
ses have identified the factor structure of the CES-D, which 
may enhance its discriminant validity [33].
Blalock et al [1] identified 4 somatic CES-D items that 
could be confounded with RA symptoms (I felt that every-
thing I did was an effort, My sleep was restless, I felt hope-
ful about the future, I could not get going). We created a 
version of the CES-D that removed these somatic items 
and prorated the remaining items to retain the range of the 
original scale.
The state scale of the Endler Multidimensional Anxiety 
Scales (EMAS). This scale was used to measure state anx-
iety [44]. The EMAS-State is a 20-item measure with each 
item rated on a 5-point intensity scale. It includes a 10-item 
cognitive-worry subscale and a 10-item autonomic-emo-
tional scale. Previous studies report good reliability for 
both scales (0.84 or better). Fifield [45] has reported that ad-
ministration by telephone and questionnaire produce com-
parable results
The Positive and Negative Affect Schedule (PANAS). The 
PANAS [32] was used as the measure of positive and neg-
ative affect. The measure includes two 10-item mood scales 
for NA and PA, which form independent factors. Each 
item is rated on a 5-point scale from 1 indicating felt very 
slightly or not at all  to 5 indicating felt very much.  Wat-
son et al [32] have reported extensively on the reliability 
and validity of the scales, finding strong convergent and 
discriminant validity with other lengthier mood measures 
[32]. We used the time frame that refers to over the past 
week  to make the PANAS comparable to the CES-D and 
the EMAS. Fifield [45] has reported that administration by 
telephone and questionnaire produce comparable results
Diagnosis of affective disorder (MD, GAD, CD). DSM-IV 
[40] criteria to qualify for a diagnosis of MD include 1) de-
pressed mood or loss of interest and pleasure in things that 
the individual usually cared about or enjoyed every day or 
nearly every day for 2 weeks or more at some time in the 
past while experiencing impaired role functioning; and 2) 
4 of 8 additional symptoms: problems with appetite, sleep, 
fatigue, energy, interest, self worth, cognition, or suicidal 
ideas. The episode could not be due to injury, illness, med-
ication or alcohol, childbirth, or the loss of a loved one 
within certain time parameters. A diagnosis of current MD 
required that symptoms occurred within 3 weeks of the in-
terview, whereas a diagnosis of lifetime MD required that 
the symptoms occurred anytime in the past but not in the 
past 3 weeks.
DSM-IV criteria for GAD include 1) excessive anxiety 
and worry for 6 months; 2) difficulty controlling worry; and 
3) at least 3 of the following 6 symptoms experienced nearly 
every day during the episode: restlessness, being easily fa-
tigued, difficulty concentrating or mind going blank, irritabil-
ity, muscle tension, sleep disturbance. Symptoms cannot be 
due to the direct effects of a substance or medical condition, 
they must manifest themselves in role impairment, and they 
cannot be exclusively coincident with mood disorder. Cur-
rent GAD required all of these criteria within the 6 months 
preceding the interview, whereas lifetime GAD required the 
same criteria for 6 months in the past prior to that time.
DSM-IV does not include criteria for a CD. Previous 
studies show that those meeting criteria for both disorders 
have more severe and persistent emotional symptoms with 
more handicapped social lives [46, 47]. Therefore, we clas-
sified people who met full criteria for both MD and GAD 
as CD for the preliminary analysis. For the ROC analysis, 
people with CD are combined with the people diagnosed 
with MD or GAD in a general affective disorder category 
(n = 37) or, in the analyses attempting to discriminate be-
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tween MD and GAD, they are eliminated (n = 27) because 
they can not be placed in either group.
Statistical analysis.We use a variety of methods to 
assess the effectiveness of the 3 scales to discriminate be-
tween those with anxiety, depression, both, or neither. Pre-
liminary analyses of convergent and discriminant validity 
include bivariate correlations among the full and subscales 
and analysis of variance (ANOVA) tests of the differences 
in mean scale scores by affective disorder (MD, GAD, CD). 
We used Scheffe and Bonferroni tests for multiple post hoc 
comparisons between the groups. ROC curves simultane-
ously estimate the sensitivity and specificity of the screen-
ing scales, and provide significance tests for the differences 
between scales. ROC analysis has been used in other stud-
ies to assess the sensitivity and specificity of screening tests 
for depression and/or anxiety [15-17, 48]. However, ROC 
analysis cannot evaluate the combined effect of subscales 
to discriminate between groups. Interaction terms created 
by multiplying subscale scores provide this information, 
but cannot be used in ROC analysis. Therefore, we tested 
the possibility that the interaction between the PA and de-
pressed affect (DA) subscales of the CES-D and the PA and 
NA subscales of the PANAS scale provide more informa-
tion than the full scale or than the subscales in an additive 
logistic regression model.
The specificity and the sensitivity rates for each scale 
provide information about the ability of the instruments to 
discriminate between those with a disorder and those with-
out, and between disorders (MD and GAD). Determining 
specificity and sensitivity usually requires choosing cut off 
scores for the continuous scales, therefore making the re-
sults dependent on the selected cut off. Somoza and Moss-
man [49] and Metz [50] suggest ROC analysis as a way to 
overcome the problem of having several cut off scores or 
selecting only one. ROC analysis provides an overall de-
scription of a scale’s combined sensitivity and specificity 
(ability to discriminate) throughout its entire range of pos-
sible cut off scores, summarized in an area score (Az).
ROC analysis creates an estimated, smoothed curve 
with a confidence interval for generalizing to the popula-
tion. Generalizing requires assuming that the scale’s scores 
are normally distributed within each of the groups (disor-
der/no disorder or MD/GAD), even if the means in each 
group are different (binormal assumption). Swets [51] indi-
cates that the binormal assumption is valid for a wide vari-
ety of diagnostic tests, and Hanley [52] describes ROC anal-
ysis as robust to deviations from normality. We used the 
CLABROC program, part of the ROCKIT software [53], to 
conduct the ROC analysis. CLABROC is a maximum likeli-
hood program that creates estimated curves for correlated, 
paired, continuous distributions. The output from the 
CLABROC program provides information to create ROC 
curves, a confidence interval around the area under the 
curve (Az), and comparisons between 2 scales on the same 
group of people. The Az parameter indicates how much 
the scale improves discrimination over chance. The Az is 
an overall index of the accuracy of the scale. Higher Az 
scores indicate greater combined sensitivity and specificity. 
Differences in the accuracy of the scales were tested using 
the area under the curve test (95% confidence level, 2-tailed 
test). According to Mossman and Somoza [54], the Az rep-
resents the probability that 1 of the patients who was diag-
nosed with the scale as having an affective disorder ranked 
higher on a particular scale than another patient, who was 
randomly identified and did not have an affective disorder, 
ranked on the same particular scale.
To use the ROC analysis to select an optimum cut-off 
score for a scale, prevalence rates need to be specified be-
cause discrimination by score varies by prevalence. Be-
cause the optimal cut-off scores depend on the prevalence 
in the population and the research/clinical situation, it is 
impossible to provide a single best score. However, we cal-
culated the true positive rate and the false positive rate for 
various cut off scores for all of the scales (available from 
the first author) [16].
Logistic regression analysis provides a way to assess 
the effectiveness of combinations of the subscales (interac-
tion terms) to discriminate between those with and those 
without an affective disorder, or between disorders. Inter-
action terms that combine information from the PA and 
NA subscales of the PANAS and the PA and DA subscales 
of CES-D should have larger coefficients than either scale 
alone if Clark and Watson’s [14] tripartitie model of affec-
tive disorder is correct. However, a problem arises when 
trying to interpret odds ratios when the independent vari-
ables are continuous. Because the coefficients describe 
changes per unit change in the independent variable, for 
the coefficients to be comparable, the independent variables 
need to be standardized by subtracting the scale mean from 
each value of the independent variable and dividing by the 
standard deviation of the independent variable.
Results
Sample description and prevalence of affective disor-
ders. Similar to the RA population, most of the study par-
ticipants are women (83%) and married (68%), but only 
one-third are currently employed (35%). At entry into the 
study, participants had been living with a diagnosis of RA 
for an average of 10 years; the mean age at diagnosis was 
39.5 years. Median family income was $35,000 and median 
education was 1 year of post-high school education. Aver-
age pain and fatigue levels in the sample during the eighth 
wave of the study were at the middle of the range (45 for 
pain, 51 for fatigue). Of the 415 participants in this study, 
9% met the criteria for current major depressive episode 
(MD = 4%), current generalized anxiety disorder (GAD = 
3%), or both simultaneously (CD = 2%).
Means and alpha reliabilities of the scales. All of 
the screening scales had adequate alpha reliabilities (Ta-
ble 1). The lowest was 0.71 for the interpersonal subscale 
of the CES-D, the highest is 0.93 for the EMAS summary 
scale. We also constructed a CES-D scale with the somatic 
items removed (CES-Dnoso). The items for this scale were 
prorated to make a scale with the same possible range of 
scores as the original CES-D scale. The mean for the scale 
without the somatic items (mean = 10.17) is lower than for 
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the scale with the somatic items (mean = 12.23, paired t-test 
P < 0.05); however, the 2 scales were almost perfectly cor-
related (0.99). Squaring this coefficient (R2 = 0.97) indicates 
that less than 3% of the original CES-D score is explained 
by the somatic items. Although the scores were signifi-
cantly lower when the somatic items were removed, sug-
gesting some RA contamination, the magnitude of the dif-
ference is small. We further explore how much the somatic 
items inflate the CES-D scores among people with RA us-
ing the ROC analyses. 
 Correlations among the scales and subscales. Table 
2 provides the correlations among the scales and subscales 
for all of the cases (n = 415, bottom half of the diagonal) 
and for just those cases with an affective disorder (n = 37, 
top half of the diagonal). 
We focus first on the correlations in the entire sample. 
The first 5 columns contain the subscales of the CES-D, as 
identified by Sheehan et al [33]. All of the correlations are 
above 0.60, indicating adequate convergent validity. All 
of the subscales had strong positive correlations with the 
full scale (0.80-0.93). These patterns of correlations pro-
vide evidence of good convergent validity for the CES-D 
subscales.
Next, we assessed the correlations between the sub-
scales of the CES-D and the subscales of the EMAS and 
the PANAS. Some of the correlations between the depres-
sion subscales and the anxiety subscales are quite high (5 
correlations are higher than 0.70, the lowest was 0.43). The 
strong positive correlation between both the depression 
subscales (CES-D) and the anxiety subscales (EMAS) and 
NA indicates that both scales were tapping negative affect. 
NA and PA had, as they should, a modest correlation (r = 
0.36).The correlations for study participants with a diagno-
sis of either MD or GAD (n = 27) are similar to the full sam-
ple. The smallest correlation is -0.05, the largest is 0.86. The 
overall pattern of correlations among those with an affec-
tive disorder is similar to the pattern among all study par-
ticipants; there is better convergent validity than discrimi-
nant validity.
Distinguishing between MD, GAD, and CD. We 
compared mean CES-D, NA, PA, and EMAS scores for 
those with no affective disorder (n = 378), those with MD 
(n = 16), GAD (n = 11), and CD (n = 10) using ANOVA (Ta-
ble 3). 
The group without an affective disorder had lower av-
erage scores on all of the scales than the groups with a dis-
order. The average scores for those in the affective disor-
der categories were at least 1 standard deviation above the 
mean for all scales. These results indicate that each of the 
screening questionnaires were able to distinguish between 
individuals with an affective disorder and those without 
one. There were large overlaps in the confidence intervals 
between types of disorders (GAD, MD, or CD), suggesting 
that none of the scales were able to differentiate between 
the types of disorders. Furthermore, the subscales showed 
no apparent advantage over the full CES-D or EMAS. PA 
scores were comparable for those with GAD, MD, or both.
Table 1. Means and reliabilities for the CES-D, EMAS, and PA-
NAS with subscales (n = 415)*
                                                                                    Alpha 
Scale Mean    SD      reliability Min-max
CES-D 12.23 11.00 0.75 0-50
   CES-Dnoso 10.17 10.73 0.72 0-47
CES-D subscales        
   Somatic 5.79 4.44 0.83 0-21
   Interpersonal 0.96 1.68 0.71 0-10
   Depressive 2.66 3.37 0.88 0-15
   Positive 9.19 3.02 0.83 0-12
EMAS 29.83 12.05 0.93 20-84
   Autonomic worry 14.50 5.76 0.83 10-40
   Cognitive worry 15.21 6.95 0.91 10-40
PANAS positive affect     
   scale 30.49 7.98 0.89 10-50
PANAS negative affect  
   scale 17.69 7.48 0.91 10-50
  * CES-D = Center for Epidemiological Studies Depression Scale; 
EMAS = Endler Multidimensional Anxiety Scales; PANAS = Positive 
and Negative Affect Schedule; SD = standard deviation; Min = min-
imum; max = maximum; CES-Dnoso = CES-D with somatic items 
removed.
Table 2. Correlations among the scales and subscales*
 1 2 3 4 5 6 7 8 9 10
1 CES-D interpersonal  0.46 0.56 0.51 0.76 0.48 0.35 0.45 0.25 0.46
2 CES-D somatic vegitative 0.63  0.70 0.32 0.85 0.53 0.34 0.47 0.22 0.41
3 CES-D depressed affect 0.73 0.79  0.34 0.86 0.47 0.27 0.40 0.33 0.51
4 CES-D positive affect (reversed) 0.60 0.61 0.68  0.64 0.38 0.08 0.25 0.41 0.45
5 CES-D summary score 0.80 0.91 0.93 0.82  0.59 0.34 0.50 0.37 0.57
6 EMAS cognitive worry 0.65 0.73 0.70 0.59 0.77  0.72 0.93 0.09 0.53
7 EMAS autonomic worry 0.52 0.65 0.57 0.43 0.63 0.75  0.92 -0.20 0.30
8 EMAS summary score 0.63 0.74 0.69 0.56 0.76 0.95 0.92  -0.05 0.45
9 Positive affect (reversed) 0.41 0.49 0.47 0.63 0.58 0.41 0.30 0.38  0.10
10 Negative affect 0.67 0.72 0.75 0.60 0.79 0.76 0.64 0.75 0.36 
  * Bottom half contains all study participants (n = 415), top half (italics) contains just those with an affective disorder (n = 37). All of the correla-
tions in the bottom left half are significant at the 0.01 level (2-tailed) (n = 415). All of the correlations in the top right half are significant at the 0.05 
level (2-tailed) except for those in bold (P values are greater than 0.05) (n = 37). See Table 1 for definitions.
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ROC analysis. We first used ROC analysis to test the 
ability of the scales and subscales to discriminate between 
those with GAD and those with MD (n = 27). Because the 
CD participants fit in neither group, they are omitted from 
this analysis and only are incorporated in the analysis of 
those with and those without a disorder. All of the scales 
showed poor discriminant validity (Az scores range from 
0.45 to 0.66; none were significantly better than chance). 
Only 2 of the subscales had Az scores that were different 
from their full scales: the interpersonal and DA subscales of 
the CES-D were each significantly worse than the full CES-
D at discriminating between depression and anxiety.
Figure 1 shows the ROC analyses of the full scales us-
ing affective disorder (AD), that is MD or GAD or both, as 
the criterion. The ROC curves for the CES-D, NA, EMAS, 
and PA show areas under the curve ranging from a high of 
0.92 for the CES-D to 0.82 for the PA. The CES-D had a sig-
nificantly higher area under the curve than the EMAS (Az 
= 0.92 versus 0.82; P = 0.003) and the PA (Az = 0.92 versus 
0.82; P = 0.003), but not the NA. These results indicate that 
the CES-D is better than the EMAS, PA, or NA at differ-
entiating between those with and those without an affec-
tive disorder. Although not shown in the figure, the curve 
for the CES-D without the somatic items was not different 
from the CES-D with the somatic items. 
All of the Azs were high, suggesting that all of the 
scales had good combined sensitivity and specificity (all 
are higher than 0.80) to predict membership in the affec-
tive disorder group compared with the nonaffective disor-
der group. We also tested the subscales of the CES-D and 
the EMAS compared with the full scales to ascertain if they 
added information hidden in the combined scales (Figure 
2). None of the subscales had significantly higher Az scores 
than the full scales. The interpersonal, DA, and PA sub-
scales had significantly lower Az scores than the full CES-
D scale. 
Logistic regression analysis. We tested the possibil-
ity that the interaction between the PA and DA subscales 
of the CES-D and the PA and NA subscales of the PANAS 
scale provide more information than either full scale or 
than the subscales in an additive logistic regression model. 
The EMAS subscales have not previously been examined 
for interactive effects; however, we decided to test the pos-
sibility that the subscales might be more effective than the 
full scale in a fashion parallel to the CES-D and PANAS. 
We focused only on the whole sample (n = 415) because 
the disordered subsample did not have sufficient cases for 
the analysis (the Hoesmer-Lemeshow test showed that sev-
eral categories had fewer than the minimum required 5 ex-
pected cases).
Table 3. Means, SDs, and 95% CIs for the scales by affective disorder category*
Scale Affective disorder category N                       Mean              SD                          95% CI
Positive affect No disorder 378 31.30 7.62 30.53-32.07
 MD 16 22.81 7.53 18.80-26.82
 GAD 11 22.18 6.66 17.71-26.66
 CD 10 21.40 6.69 16.62-26.18
Negative affect No disorder 378 16.66 6.62 15.99-17.33
 MD 16 27.25 7.61 23.19-31.31
 GAD 11 28.73 9.26 22.50-34.95
 CD 10 29.10 6.74 24.28-33.92
EMAS No disorder 378 28.40 10.64 27.33-29.48
 MD 16 47.94 16.84 38.96-56.91
 GAD 11 41.09 16.08 30.29-51.89
 CD 10 42.30 13.74 32.47-52.13
CES-D No disorder 378 10.48 9.38 9.53-11.42
 MD 16 30.94 10.00 25.61-36.26
 GAD 11 27.27 10.07 20.51-34.04
 CD 10 32.20 11.37 24.07-40.33
CES-Dnoso No disorder 378 8.46 9.09 7.54-9.38
 MD 16 27.97 10.06 22.61-33.33
 GAD 10 24.50 10.66 16.88-32.12
 CD 10 29.63 12.15 20.93-38.32
  * SDs = standard deviations; 95% CIs = 95% confidence intervals; MD = major depression; GAD = generalized anxiety disorder; CD = comorbid 
disorder. See Table 1 for other definitions.
Figure 1. Receiver operator characteristic curves for the full 
scales (Center for Epidemiological Studies Depression Scale 
[CES-D], negative affect [NA], Endler Multidimensional Anxi-
ety Scales [EMAS], and positive affect [PA].
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The logistic regression analysis revealed that both 
the full CES-D and the PA and DA subscales of the CES-
D showed significant positive associations with the likeli-
hood of having an affective disorder diagnosis. Combin-
ing information from the DA and PA subscales does not 
contribute to the simple additive model. The pattern is the 
same for the PANAS, but slightly different for the EMAS. 
For the EMAS, when both of the subscales (autonomic 
worry and cognitive worry) were in the model, the auto-
nomic worry subscale ceased to be a significant predictor, 
suggesting that there was considerable overlap between 
these subscales.
Cut point for the CES-D. ROC analysis also allowed us 
to evaluate the best cut point for determining membership 
in the affective disorder category. The generally accepted 
cut point for the CES-D is 16. Some researchers have ques-
tioned the applicability of this value for the RA population 
because of the possible criterion contamination of the so-
matic items. We saw little evidence of contamination. Both 
the false positives and the true positives increased substan-
tially when the cut point scores were increased from 17.5 to 
20.5. There was very little difference between scores of 16.5 
and 17.5.
The ROC program automatically selects cut point 
scores from the raw data. Because cut points of 16 and 19 
have been suggested in past research, we examined these 2 
cut point scores for the full CES-D and the CES-Dnoso (so-
matic items removed) using simple cross-tabulated data 
(Table 4). In this sample, there was a difference of only 1 
true  case missed when 19 was used as a cut score, com-
pared with 16, but there were 22 more false positives with 
16. Like other studies using the CES-D, we found that the 
specificity (0.89) of the CES-D is much better than the sensi-
tivity (0.24) at the standard cut off score of 16. 
 
Discussion
This study provided a unique opportunity to review 
the usefulness of 3 popular scales of depression and anxiety 
for use as screeners in RA research. Its uniqueness stems 
from the national representative sample and the availabil-
ity of both screener and diagnostic interview scores. Using 
these data, we found that it is possible to detect affective 
disorders among people with RA using short symptom 
scales. Furthermore, we found much lower rates of depres-
sion and anxiety in this sample than reported in other RA 
studies; the percentages are closer to the national average 
than previously found in RA samples [55]. We do not attri-
bute this lower rate to our decision to exclude dysthymia 
from our analyses, because only an additional 2% of the 
sample (8 cases) met criteria for dysthymia only. Rather, 
we conclude that higher rates of depression and depres-
sive symptoms found in other studies are more likely due 
to the characteristics of the samples than weaknesses in the 
scales, because the scales, particularly the CES-D, demon-
strated high combined sensitivity and specificity.
Similar to Breslau [12], we found that the CES-D does 
not differentiate between MD and GAD, but does detect 
high levels of depression and anxiety equally well. None of 
the self-report measures of distress discriminated between 
DSM-IV MD and GAD. Despite the promise of Clark and 
Watson’s [14] tripartite model for differentiating between 
anxiety and depression using positive and negative affect 
subscales, PA did not differentiate between MD and GAD 
in this sample. We do not have a satisfactory explanation 
for this result. Possible explanations include sample-spe-
cific findings, a small number of individuals with MD or 
GAD, something particular about the RA population, or 
that MD and GAD share too much of a common core to be 
discernible with general scales. The evidence of comorbid-
ity in this and other studies suggests that differentiating be-
tween MD and GAD may be less important than identify-
ing the existence of an affective disorder.
Figure 2. Receiver operator characteristic curves for the full 
and subscales of the Center for Epidemiological Studies De-
pression Scale (CESD) and Endler Multidimensional Anxi-
ety Scales (EMAS) (n = 415). CESD-DA = CESD depressed af-
fect; CESD-SV = CESD somatic vegitative; CESD-PA = CESD 
positive affect; CESD-IN = CESD interpersonal; EMAS-AW 
= EMAS autonomic worry; EMAS-CW = EMAS cognitive 
worry.
Table 4. Comparing the CES-D and the CES-Dnoso at 2 conventional cut points (n = 415)*
                                                                                             True positives                      False 
Scale                             Cut point                  n (%)                  missed                         positives                   Sensitivity                Specificity
CES-D 16 122 (29) 4 89 0.89 0.24
CES-Dnoso 16 114 (27) 4 81 0.89 0.21
CES-D 19 99 (24) 5 67 0.86 0.18
CES-Dnoso 19 86 (21) 8 57 0.78 0.15
  * CES-D = Center for Epidemiological Studies Depression Scale; CES-Dnoso = CES-D with somatic items removed.
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Because the consequences of comorbidity are quite 
high, physicians should attempt to detect and treat those 
cases that emerge. In addition to RA-affective disorder co-
morbidity, there is evidence of comorbidity among anx-
iety disorders. Fifty to sixty percent of individuals who 
meet criteria for 1 anxiety disorder diagnosis also meet cri-
teria for additional comorbid anxiety diagnoses [56]. Indi-
viduals with anxiety disorders are also likely to have ma-
jor depression and substance use disorders [57]. When they 
occur together, anxiety disorders tend to precede the de-
velopment of mood disorders, such as depression or sub-
stance use [58]. This temporal ordering suggests that anxi-
ety may contribute to the development of other psychiatric 
problems, making early detection a high priority.
What do these results suggest for clinical practice and 
future research on RA/affective disorder connections? In 
clinical practices where the costs of false positives are low, 
using a cut point of 16 for the CES-D with followup screen-
ing seems prudent. In prevalence research where questions 
about the relationship between RA and affective disorders 
are the focus, a cut point of 19 for the CES-D is more con-
servative and therefore preferable. If interview time is lim-
ited, using the DA subscale of the CES-D is almost as reli-
able as the full scale; however, cut points for the subscale 
need to be established.
Researchers should be cautious in assuming a higher 
prevalence of MD or GAD in RA populations. This study, 
using a representative sample and diagnostic interview 
schedule derived diagnoses, shows similar rates to a gen-
eral population national survey. Despite similar numbers, 
because the consequences of comorbidity are greater than 
each disorder alone, it is essential to identify those meet-
ing criteria for both affective disorders, and to continue to 
explore connections between chronic illnesses such as RA 
and affective disorders.
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